Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia ( iceCivils de Lyon University of Lyon...)

HOME >> MEDICINE >> TECHNOLOGY

Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia

ice Civils de Lyon, University of Lyon, France,

Tel +33 609 412414 (mobile),

e-mail bertrand.coiffier@chu-lyon.fr

For media relations, contact:

Adam Michael, a.michael@northbankcommunications.com, +44 (0)20 7268 3002

Annabel Entress, a.entress@northbankcommunications.com, +44 (0)20 7268 3002

Regulatory Statements

SPC2996 is a new investigational drug which is at an early stage in clinical development. It has not been approved as safe and effective for human use by any regulatory authority and Santaris Pharma is therefore unable to make it available to patients outside its clinical trial protocols.

This written announcement contains forward-looking statements, identified by the use of words such as "believes," "expects," "may," "will," "should", "potential," "anticipates," "plans" or "intends" and similar expressions. Such forward-looking statements involve risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from the future results, events or developments indicated in this announcement. Such factors include, but are not limited to the timing, success and cost of clinical studies; the ability to obtain regulatory approval of products, market acceptance of and future demand for Santaris products and the impact of competitive products and pricing. These factors should be considered carefully and readers are cautioned not to place undue reliance on such forward-looking statements. No assurance can be given that the future results covered by the forward-looking statements will be achieved. All information in this press release is as of the date of this press release and Santaris does not intend to update this information.

TECHN
'"/>

Page: 1 2 3 4 5 6 7 8 9
Related medicine technology :

1. Santaris Pharma presents positive preclinical data on SPC2996 at the American Association for Cancer Research
2. Sygnis Pharma AG announces date for presentation of clinical results
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis

Post Your Comments:

(Date:5/22/2013)... , May 22, 2013 Viral hepatitis is an ... 75 percent of those with hepatitis C are unaware they ... Testing and Awareness Day in the U.S. House of Representatives ... the Rayburn Foyer of the Rayburn House Office Building in ... American Association for the Study of Liver Diseases ( AASLD ...

(Date:5/22/2013)... N.Y. , May 22, 2013 The Leukemia ... million to Valor Biotherapeutics, LLC, a joint venture ... pre-clinical development, manufacturing, and a Phase I clinical trial ... poor outcomes faced by many patients with indolent lymphomas ... Valor,s protein, IGN002, is a new ...

(Date:5/22/2013)... CAESAREA, Israel , May 22, 2013 /PRNewswire/ ... data presented from the DEFLECT-I study demonstrates that Keystone ... lesion volume during TAVR (Transcatheter Aortic Valve Replacement) procedures ... Scientific Advisory Board announces consensus on the importance of ... importance and need for cerebral protection during cardiovascular procedures ...

Breaking Medicine Technology:Hepatitis Awareness: Bringing Attention to a Silent Epidemic 2 The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2 The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3 The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4 New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 2 New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 3 New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 4

[0] Hepatitis Awareness: Bringing Attention to a Silent Epidemic [0] The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients [0] New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR

... Medical AB ( http://www.omxgroup.com, OMX: DIAM B; ... http://www.otcqx.com, OTC: ... B)(OTC: DMYDY)announced today that the Swedish Medical Products,Agency (MPA) has ... therapeutic diabetes vaccine Diamyd(R)., (Logo: http://www.newscom.com/cgi-bin/prnh/20080314/297194 ), ...

... Onset with SYMBICORT with Improved Lung Function within ... ... WILMINGTON, Del., March 18 Data from a new,study demonstrated ... greater,and faster bronchodilatory effects, or opening of the airways, compared,with ...

Cached Medicine Technology:Diamyd(R) Diabetes Vaccine Receives Approval to Start Phase III Trials in Europe 2 Study Compares Bronchodilatory Effects of SYMBICORT(R) and Advair in Adults With Asthma 2 Study Compares Bronchodilatory Effects of SYMBICORT(R) and Advair in Adults With Asthma 3 Study Compares Bronchodilatory Effects of SYMBICORT(R) and Advair in Adults With Asthma 4

Diamyd(R) Diabetes Vaccine Receives Approval to Start Phase III Trials in Europe Study Compares Bronchodilatory Effects of SYMBICORT(R) and Advair in Adults With Asthma

(Date:5/22/2013)... May 22, 2013 People in the United ... leading to water shortages. In much of the world, water ... water advocate, Sharon Kleyne. She warns against taking water for ... that is available so easily in the United States. , ... of Water radio show, heard live or by podcast on ...

(Date:5/22/2013)... 2013 DePuy Pinnacle lawsuit ... Hip Replacement System continue to move forward in the ... LLP reports. According to an Order dated May ... monitoring reports associated with a 2007 criminal investigation by ... practices. Plaintiffs maintained in their December 2012 ...

(Date:5/22/2013)... (PRWEB) May 22, 2013 Diversity Focus ... Handicap This! The performance promotes awareness that physical ... The Handicap This! performance will be held Friday, June ... School auditorium. Tickets for Handicap This! can be ... helps audiences measure the level to which their mind ...

(Date:5/22/2013)... 2013 Twenty student-led startup companies at ... in an intensive startup accelerator designed to help them ... and create local jobs as part of ASU’s ... Edson initiative offers approximately 20 student teams up to ... training to launch their for-profit, more-than-profit or nonprofit ventures. ...

(Date:5/22/2013)... study challenges previous research that suggests umpire discrimination ... a collaboration between researchers at U-M and the ... the controversial argument over whether MLB umpires discriminate ... the same race. It found little statistical evidence ... professor of sport management at the U-M School ...

[0] Water Advocate Sharon Kleyne Announces Water Conservation Appreciation [0] DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation [0] Handicap This! Comes to Marion, Iowa [0] ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort [0] U-M study challenges notion that umpires call more strikes for pitchers of same race

... From the Underbelly, star Rachael Harris and ,Iron Chef, judge and,Mom-a-licious creator Domenica ... ... LOS ANGELES, March 26 The Fourth Annual Open Toe Shoe,Party will ... Hotel. The event will raise funds for The One Small Voice,Foundation., "All ...

... WetFeet Co-founder and CEO Gary Alpert to Lead Company,s Partnership ... ... Caring.com is pleased to,announce the arrival of Gary Alpert ... be responsible for the company,s,partnership and content licensing programs., ...

... An annual analysis,to help health leaders identify areas ... includes important information such as each state,s,rate of ... number,of specialist doctors., Those and other measures ... the 2007 State Snapshots released today by the ...

... Dementia Patients Through Grant, MIAMI, March 26 ... grant to the Center on Aging-University of Miami Miller,School ... a,computer-integrated system for family caregivers of dementia patients., ... care to someone,suffering from dementia who is 50 years ...

... 700 Frontline Clinicians Committed to Improving ... 26 The American Headache Society,(AHA), ... (AOAAM), American,Society of Pain Educators (ASPE), ... National Fibromyalgia Research,Association (NFRA), National Stroke ...

... the Concerns of General Dentists and Their Patients, ... second annual advocacy conference, A Great Dentist Goes to,Washington, ... constituent,leaders and member general dentists from 30 states learned ... sophisticated skills to more,than 100 Congressional offices on Capitol ...

Cached Medicine News:Health News:Celebrities From All Walks of Life Put Their Best Foot Forward for the Fourth Annual Open Toe Shoe Party 2 Health News:Caring.com Adds Vice President of Business Development 2 Health News:AHRQ's 2007 State Snapshots Provide Broader Portraits of State-By-State Health Care Performance 2 Health News:AHRQ's 2007 State Snapshots Provide Broader Portraits of State-By-State Health Care Performance 3 Health News:AT&T Announces Grant to Center on Aging-University of Miami Miller School of Medicine 2 Health News:AT&T Announces Grant to Center on Aging-University of Miami Miller School of Medicine 3 Health News:National Pain Organizations Converge at PAINWeek(TM) 2008 2 Health News:National Pain Organizations Converge at PAINWeek(TM) 2008 3 Health News:AGD Advocacy Conference Connects General Dentists with Congress 2

Celebrities From All Walks of Life Put Their Best Foot Forward for the Fourth Annual Open Toe Shoe Party Caring.com Adds Vice President of Business Development AHRQ's 2007 State Snapshots Provide Broader Portraits of State-By-State Health Care Performance AT&T Announces Grant to Center on Aging-University of Miami Miller School of Medicine National Pain Organizations Converge at PAINWeek(TM) 2008 AGD Advocacy Conference Connects General Dentists with Congress

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

Medicine Products:

Ponstel Poliovirus Culture PML/RARa t(15;17) Translocation by RT-PCR Platelet Neutralization Procedure